Sfoglia per Autore

Opzioni
Mostrati risultati da 1 a 20 di 45
Titolo Tipologia Data di pubblicazione Autori File
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 02 - Intervento a convegno 2003 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERACAZZANIGA, GIOVANNI ITALOBIONDI, ANDREAPOGLIANI, ENRICO MARIACORNEO, GIANMARCOGAMBACORTI PASSERINI, CARLO +
Response to 'D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients' by Leguay et al 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 01 - Articolo su rivista 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis 02 - Intervento a convegno 2005 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAFRANCESCHINO, ANNAGAMBACORTI PASSERINI, CARLO +
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 01 - Articolo su rivista 2006 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAPOGLIANI, ENRICO MARIAGAMBACORTI PASSERINI, CARLO +
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl(+) neoplastic cells 01 - Articolo su rivista 2006 PUTTINI, MIRIAMREDAELLI, SARAPIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
BIM promoter is epigenetically silenced in malignant lymphoid cells, leading to downregulation of BIM expression and protection from apoptosis 02 - Intervento a convegno 2006 MAGISTRONI, VERAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLO +
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 02 - Intervento a convegno 2006 PUTTINI, MIRIAMFRANCESCHINO, ANNAREDAELLI, SARAPIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Epigenetic changes at the bim locus associated with glucocorticoid resistance in human lymphoid malignancies 02 - Intervento a convegno 2007 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Mechanisms of Bim epigenetic silencing in anaplastic large cell lymphoma 02 - Intervento a convegno 2008 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Reversal of glucocorticoid resistance in human lymphoid malignancies with histone deacetylase inhibitors 02 - Intervento a convegno 2008 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 02 - Intervento a convegno 2008 REDAELLI, SARAPIAZZA, ROCCO GIOVANNIROSTAGNO, ROBERTASASSONE, MARIANNA CAROLINAMAGISTRONI, VERAPERINI, PIETROMAREGA, MANUELAGAMBACORTI PASSERINI, CARLO +
Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition 02 - Intervento a convegno 2009 PIAZZA, ROCCO GIOVANNIMOGAVERO, ANGELAMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 01 - Articolo su rivista 2009 REDAELLI, SARAPIAZZA, ROCCO GIOVANNIROSTAGNO, ROBERTAMAGISTRONI, VERAPERINI, PIETROMAREGA, MANUELAGAMBACORTI PASSERINI, CARLO +
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells 01 - Articolo su rivista 2009 MOLOGNI, LUCAMAGISTRONI, VERAPIAZZA, ROCCO GIOVANNIGAMBACORTI PASSERINI, CARLO +
Role of TMPRSS2/ERG in cellular transformation 02 - Intervento a convegno 2009 MAGISTRONI, VERAMOLOGNI, LUCAGAMBACORTI PASSERINI, CARLO +
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 01 - Articolo su rivista 2010 PIAZZA, ROCCO GIOVANNIMOGAVERO, ANGELAMAGISTRONI, VERACazzaniga, GBIONDI, ANDREAGAMBACORTI PASSERINI, CARLO +
Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2 01 - Articolo su rivista 2010 MOLOGNI, LUCACECCON, MONICAPURGANTE, STEFANIAMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Reactivation of an Epigenetic Silenced Tumor Suppressor Gene BIM in Anaplastic Large Cell Lymphoma Leads to massive Apoptosis 02 - Intervento a convegno 2010 PIAZZA, ROCCO GIOVANNIMAGISTRONI, VERAGAMBACORTI PASSERINI, CARLO +
Mostrati risultati da 1 a 20 di 45
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile